NextCure Inc (NXTC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $30.59M
Last updated: Nov 17, 2026 at 4:10 PM ET
NextCure Inc (NXTC) Stock Chart
NextCure (NXTC) has a latest price of $6.70 on Nov 17, 2026, 57.4% below its 52-week high of $15.74. Its price fell 32.2% over the past 12 months. The month-end price fell 93.6% over the 5 years through Oct 2026, a compound annual decline of 42.3%.
Price Chart
From May 2019 to Oct 2026, its highest month-end close was $676.23 in Dec 2019 and its lowest $1.60 in Jun 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NXTC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NXTC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 1.2%, and over 6 months it fell 26.6%. The month-end price fell 49.0% over the 3 years through Oct 2026, a compound annual decline of 20.1%.
| Period | Change |
|---|---|
| 1 month | +18.2% |
| 3 months | -1.2% |
| 6 months | -26.6% |
| 12 months | -32.2% |
| 12 months, with dividends | -32.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -49.0% | -20.1% |
| 5 years | -93.6% | -42.3% |
Price by Year
Its best calendar year was 2025, when the price rose 53.3%, and its weakest was 2020, when it fell 80.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $6.31 | -55.5% |
| 2025 | $14.19 | +53.3% |
| 2024 | $9.26 | -32.4% |
| 2023 | $13.69 | -19.1% |
| 2022 | $16.93 | -76.5% |
| 2021 | $72.03 | -45.0% |
| 2020 | $130.85 | -80.6% |
Trading Range
The price is 13.0% above its 50-day average of $5.93 and 10.6% below its 200-day average of $7.49.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $6.70 | |
| 52-week high | $15.74 | -57.4% |
| 52-week low | $1.55 | +332.3% |
| 50-day average | $5.93 | +13.0% |
| 200-day average | $7.49 | -10.6% |
Price Risk
Over 3 years, its largest fall from a peak was 94.7%.
| Measure | Value |
|---|---|
| 1-year beta | 2.18 |
| Largest fall, 1 year | -88.8% |
| Largest fall, 3 years | -94.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NXTC
What is NXTC's 1-year price change?
NextCure's price fell 32.2% over the past 12 months. With dividends included, the 12-month total return was -32.2%.
What is NXTC's 5-year price change?
NextCure's month-end price fell 93.6% over the 5 years through Oct 2026, a compound annual decline of 42.3%. These figures leave out dividends.
What is NXTC's 52-week high and low?
NextCure's 52-week high is $15.74 and its 52-week low is $1.55. Its latest price of $6.70 on Nov 17, 2026 is 57.4% below the high.
What is NXTC's beta?
NextCure's 1-year beta against the S&P 500 is 2.18, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 88.8%.
Is the NXTC chart free?
Yes. Advanced Charting for NXTC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NXTC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors